METTL3 and urogenital neoplasm: The METTL3-mediated m6A modification level of TIMP2 mRNA may promote podocyte injury, apoptosis in glomeruli, and kidney inflammation through upregulating the Notch3 and Notch 4 signaling pathways (30).